Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05204576 · ClinicalTrials.gov registry record · NA

Computer Based Treatment for Cognitive Behavioral Therapy and Cooperative Pain Education and Self-Management

A NA study, sponsored by Yale University.

Completed
Registry status
NA
Development phase
160
Enrollment target

NCT05204576 is a NA study that has completed, run by Yale University. The registered enrollment target is 160 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05204576, a NA study, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
160 participants
Enrollment target

Study Summary

The investigators plan to develop and pilot test an integrated, web-based cognitive behavioral approach and then conduct a randomized clinical trial evaluating its efficacy relative to standard care in a large and diverse sample of individuals with chronic pain treated with buprenorphine or methadone. The new program will retain key components of Dr. Carroll's computer-based training for cognitive-behavioral therapy (CBT4CBT), including its emphasis on teaching cognitive and behavioral coping skills in an engaging way and focus on the 5 A's of MAT (Adherence, Attendance, Abstinence, Alternate Activities and Accessing support); it will add components from Dr. Heapy's COPES (Cooperative Pain Education and Self-Management) intervention (self-management of chronic pain, with daily surveys via text that monitor pain intensity and interference, physical activity, and skills practice) and modify existing CBT4CBT modules to address the complex interplay between pain and drug use in this population, emphasizing the development of generalizable skills. A randomized clinical trial evaluating CBT4CBT-COPES will be conducted in a diverse sample 160 of individuals enrolled in agonist treatment (methadone or buprenorphine) who have chronic pain, in a 3-month randomized clinical trial with a 6-month follow-up, comparing it to standard treatment alone. The primary retention outcome will be adherence with agonist treatment; the primary pain outcome will be the PROMIS 6-item Pain Interference Short Form.

Interventions

  • BEHAVIORAL CBT4CBT COPES

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2022-07-15
Est. Completion 2025-03-21
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT05204576

The ClinicalTrials.gov registry entry for NCT05204576 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which CBT4CBT COPES is the first listed.

NCT05204576 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05204576 about?

NCT05204576 is a clinical study titled "Computer Based Treatment for Cognitive Behavioral Therapy and Cooperative Pain Education and Self-Management". The investigators plan to develop and pilot test an integrated, web-based cognitive behavioral approach and then conduct a randomized clinical trial evaluating its efficacy relative to standard care in a large and diverse sample of individuals with chronic pain treated with buprenorphine or methadon...

What is the current status of trial NCT05204576?

This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2022-07-15. Estimated completion is 2025-03-21.

What interventions are being tested in trial NCT05204576?

The interventions under investigation include: CBT4CBT COPES (BEHAVIORAL).

Who is sponsoring clinical trial NCT05204576?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.